Jupiter Life Lin Q2 FY27 Results (NSE: JLHL)
Signal: Steady quarter
The read
Revenue recovered to ₹4,564.96 million, up 15.97% YoY and 11.07% QoQ, but the implied 18.47% operating margin remains below the 22-23% range seen through most of FY25-FY26 and follows Q1FY27's 19.3% margin, making margin recovery the key trajectory question.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹456.5 Cr | +15.97% | +11.07% |
| Net profit | ₹56.36 Cr | N/A | |
| EBIT margin | 18.47% |
P&L walk
Consolidated revenue was ₹4,564.96 million, up 15.97% YoY and 11.07% QoQ; the available operating-profit figure of ₹843.18 million implies an operating margin of about 18.47%, keeping profitability below the recent 22-23% margin range.
Segments
No reportable segment split is provided; the company states that healthcare services are its only reportable business and that the hotel division is below the 10% disclosure thresholds.
Key positives
- Consolidated revenue reached ₹4,564.96 million, up 15.97% YoY and 11.07% QoQ, improving from the ₹4,109.83 million reported for the immediately preceding quarter.
- The group continues to add capacity: the board approved acquisition of South Pune land for ₹150 Crores and incorporation of a wholly owned subsidiary.
- Subsidiaries covered in the review contributed ₹125.02 million of quarterly revenue and ₹20.36 million of quarterly PAT.
Key concerns
- The implied operating margin of 18.47% remains below the 22-23% range reported across much of FY25-FY26 and follows Q1FY27's 19.3% margin.
- The filing does not disclose hospital operating KPIs such as occupancy, ARPOB, case mix or volume, limiting diagnosis of the revenue and margin trajectory.
- The proposed South Pune land acquisition of ₹150 Crores adds to the expansion and capital-allocation requirements of the group.
Research and educational content only. Not investment advice.